Harold E. Varmus | Academic Influence

Why Is Harold E. Varmus Influential?

According to Wikipedia, Harold Eliot Varmus is an American Nobel Prize-winning scientist who was director of the National Institutes of Health from 1993 to 1999 and the 14th Director of the National Cancer Institute from 2010 to 2015, a post to which he was appointed by President Barack Obama. He was a co-recipient of the 1989 Nobel Prize in Physiology or Medicine for discovery of the cellular origin of retroviral oncogenes. He is currently the Lewis Thomas University Professor of Medicine at Weill Cornell Medicine and a senior associate at the New York Genome Center.

Harold E. Varmus's Published Works

Number of citations in a given year to any of this author's works

Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author

Published Papers

A new initiative on precision medicine. (2015) (3544)
Acquired Resistance of Lung Adenocarcinomas to Gefitinib or Erlotinib Is Associated with a Second Mutation in the EGFR Kinase Domain (2005) (3258)
EGF receptor gene mutations are common in lung cancers from "never smokers" and are associated with sensitivity of tumors to gefitinib and erlotinib. (2004) (3033)
Somatic mutations affect key pathways in lung adenocarcinoma (2008) (2513)
Amplification of N-myc in untreated human neuroblastomas correlates with advanced disease stage. (1984) (2129)
Proceedings of the National Academy of Sciences of the United States of America. Annual subject and author indexes. (1990) (2094)
Many tumors induced by the mouse mammary tumor virus contain a provirus integrated in the same region of the host genome (1982) (1666)
Amplified DNA with limited homology to myc cellular oncogene is shared by human neuroblastoma cell lines and a neuroblastoma tumour (1983) (1343)
DNA related to the transforming gene(s) of avian sarcoma viruses is present in normal avian DNA (1976) (1250)
KRAS Mutations and Primary Resistance of Lung Adenocarcinomas to Gefitinib or Erlotinib (2005) (1101)
Characterizing the cancer genome in lung adenocarcinoma (2007) (1074)
The molecular biology of the hepatitis B viruses. (1987) (997)
Characterization of ribosomal frameshifting in HIV-1 gag-pol expression (1988) (919)
Cloning and sequencing of a cDNA encoding DNA methyltransferase of mouse cells. The carboxyl-terminal domain of the mammalian enzymes is related to bacterial restriction methyltransferases. (1988) (858)
Structure and variability of human chromosome ends. (1990) (849)
Toward a Shared Vision for Cancer Genomic Data. (2016) (797)
Gene Mutations in Human Hæmoglobin: the Chemical Difference Between Normal and Sickle Cell Hæmoglobin (1957) (776)
Expression of the int-1 gene in transgenic mice is associated with mammary gland hyperplasia and adenocarcinomas in male and female mice (1988) (719)
A Specific Chemical Difference Between the Globins of Normal Human and Sickle-Cell Anæmia Hæmoglobin (1956) (705)
The molecular genetics of cellular oncogenes. (1984) (693)
n-Butyrate causes histone modification in HeLa and Friend erythroleukaemia cells (1977) (674)
Homogeneously staining chromosomal regions contain amplified copies of an abundantly expressed cellular oncogene (c-myc) in malignant neuroendocrine cells from a human colon carcinoma. (1983) (662)
Subtype-specific genomic alterations define new targets for soft tissue sarcoma therapy (2010) (595)
Mode of proviral activation of a putative mammary oncogene (int-1) on mouse chromosome 15 (1984) (589)
Rescuing US biomedical research from its systemic flaws (2014) (585)
Induction and apoptotic regression of lung adenocarcinomas by regulation of a K-Ras transgene in the presence and absence of tumor suppressor genes. (2001) (576)
The Knockout Mouse Project (2004) (558)
Signals for ribosomal frameshifting in the rous sarcoma virus gag-pol region (1988) (556)
Evidence that the transforming gene of avian sarcoma virus encodes a protein kinase associated with a phosphoprotein (1978) (545)
Evidence that transgenes encoding components of the Wnt signaling pathway preferentially induce mammary cancers from progenitor cells (2003) (537)
A constitutively active epidermal growth factor receptor cooperates with disruption of G1 cell-cycle arrest pathways to induce glioma-like lesions in mice. (1998) (536)
Multiple arrangements of viral DNA and an activated host oncogene in bursal lymphomas (1982) (524)
Form and function of retroviral proviruses. (1982) (522)
Inhibition of drug-resistant mutants of ABL, KIT, and EGF receptor kinases. (2005) (515)
Abnormal human haemoglobins. (1958) (506)
Glycogen synthase kinase-3 and dorsoventral patterning in Xenopus embryos (1995) (501)
A Member of the Frizzled Protein Family Mediating Axis Induction by Wnt-5A (1997) (500)
Lung adenocarcinomas induced in mice by mutant EGF receptors found in human lung cancers respond to a tyrosine kinase inhibitor or to down-regulation of the receptors. (2006) (442)
Expression of the Rous sarcoma virus pol gene by ribosomal frameshifting. (1985) (426)
A cellular oncogene (c-Ki-ras) is amplified, overexpressed, and located within karyotypic abnormalities in mouse adrenocortical tumour cells (1983) (417)
Definition of regions in human c-myc that are involved in transformation and nuclear localization. (1987) (416)
Purification and molecular cloning of a secreted, Frizzled-related antagonist of Wnt action. (1997) (409)
Requirement for Tec kinases Rlk and Itk in T cell receptor signaling and immunity. (1999) (405)
Correct integration of retroviral DNA in vitro (1987) (402)
Enhanced expression of the human gene N-myc consequent to amplification of DNA may contribute to malignant progression of neuroblastoma. (1984) (383)
A nucleoprotein complex mediates the integration of retroviral DNA. (1989) (369)
Three decades of Wnts: a personal perspective on how a scientific field developed (2012) (358)
Induction of ovarian cancer by defined multiple genetic changes in a mouse model system. (2002) (358)
Retroviral integration: structure of the initial covalent product and its precursor, and a role for the viral IN protein. (1989) (350)
Two DNA methyltransferases from murine erythroleukemia cells: purification, sequence specificity, and mode of interaction with DNA. (1983) (343)
A receptor for subgroup A Rous sarcoma virus is related to the low density lipoprotein receptor (1993) (339)
Human immunodeficiency viruses. (1986) (338)
Wnt signals across the plasma membrane to activate the β-catenin pathway by forming oligomers containing its receptors, Frizzled and LRP (2004) (334)
Ethical complexities of conducting research in developing countries. (1997) (334)
c-Src enhances the spreading of src-/- fibroblasts on fibronectin by a kinase-independent mechanism. (1995) (322)
A new nomenclature for int-1 and related genes: The Wnt gene family (1991) (321)
Mapping unintegrated avian sarcoma virus DNA: Termini of linear DNA bear 300 nucleotides present once or twice in two species of circular DNA (1978) (321)
FGF‐20 and DKK1 are transcriptional targets of β‐catenin and FGF‐20 is implicated in cancer and development (2005) (319)
Sensitivity of human lung adenocarcinoma cell lines to targeted inhibition of BET epigenetic signaling proteins (2012) (313)
Regulation of dorsal fate in the neuraxis by Wnt-1 and Wnt-3a. (1997) (311)
Chromosome localization in normal human cells and neuroblastomas of a gene related to c-myc (1984) (299)
Deficiency of p53 accelerates mammary tumorigenesis in Wnt-1 transgenic mice and promotes chromosomal instability. (1995) (298)
Polymerase gene products of hepatitis B viruses are required for genomic RNA packaging as well as for reverse transcription (1990) (298)
Molecular cloning and characterization of avian sarcoma virus circular DNA molecules (1980) (297)
Basic fibroblast growth factor induces cell migration and proliferation after glia-specific gene transfer in mice. (1998) (296)
Proviruses of avian sarcoma virus are terminally redundant, co-extensive with unintegrated linear DNA and integrated at many sites (1978) (294)
Analysis of avian leukosis virus DNA and RNA in bursal tumors: Viral gene expression is not required for maintenance of the tumor state (1981) (292)
Uninfected vertebrate cells contain a protein that is closely related to the product of the avian sarcoma virus transforming gene (src). (1979) (292)
Seeding and Propagation of Untransformed Mouse Mammary Cells in the Lung (2008) (291)
Biochemical and genetic evidence for the hepatitis B virus replication strategy. (1986) (290)
Rescue of osteoclast function by transgenic expression of kinase-deficient Src in src-/- mutant mice. (1997) (281)
Mutations associated with familial melanoma impair p16INK4 function (1995) (277)
Nucleotide sequence of an avian sarcoma virus oncogene (src) and proposed amino acid sequence for gene product (1980) (274)
Nucleosomes, DNA-binding proteins, and DNA sequence modulate retroviral integration target site selection (1992) (269)
Gene Evolution and the Hæmoglobins (1961) (262)
Epstein-Barr Virus: An Important Vaccine Target for Cancer Prevention (2011) (256)
Casein kinase 2 associates with and phosphorylates Dishevelled (1997) (255)
The New Era in Cancer Research (2006) (255)
Grand Challenges in Global Health (2003) (252)
Association of the amino‐terminal half of c‐Src with focal adhesions alters their properties and is regulated by phosphorylation of tyrosine 527. (1994) (251)
What to call the AIDS virus? (1986) (250)
Use of MMTV-Wnt-1 transgenic mice for studying the genetic basis of breast cancer (2000) (248)
Identification of a human gene (HCK) that encodes a protein-tyrosine kinase and is expressed in hemopoietic cells. (1987) (238)
Regulation of Wnt Signaling by Sox Proteins: XSox17α/β and XSox3 Physically Interact with β-catenin (1999) (237)
Human N-myc gene contributes to neoplastic transformation of mammalian cells in culture (1985) (237)
Human immunodeficiency virus type 1 integrase mutants retain in vitro integrase activity yet fail to integrate viral DNA efficiently during infection (1996) (236)
Dexamethasone-mediated induction of mouse mammary tumor virus RNA: a system for studying glucocorticoid action (1975) (236)
Purification of DNA complementary to nucleotide sequences required for neoplastic transformation of fibroblasts by avian sarcoma viruses. (1976) (234)
Molecular biology of tumor viruses. RNA tumor viruses. (1982) (228)
Association of p60c-src with endosomal membranes in mammalian fibroblasts (1992) (227)
Expression of the proto-oncogene int-1 is restricted to postmeiotic male germ cells and the neural tube of mid-gestational embryos (1987) (226)
Functional overlap in the src gene family: inactivation of hck and fgr impairs natural immunity. (1994) (221)
The structure of haemoglobin - IV. Sign determination by the isomorphous replacement method (1954) (220)
Nucleotide sequences at host–proviral junctions for mouse mammary tumour virus (1981) (217)
Cellular functions are required for the synthesis and integration of avian sarcoma virus-specific DNA (1977) (210)
Nucleotide sequences related to the transforming gene of avian sarcoma virus are present in DNA of uninfected vertebrates. (1978) (210)
Retroviruses as mutagens: Insertion and excision of a nontransforming provirus alter expression of a resident transforming provirus (1981) (207)
Inhibition of secretion of hepatitis B surface antigen by a related presurface polypeptide. (1986) (205)
The hemoglobins in genetics and evolution (1963) (205)
Endogenous mammary tumour virus DNA varies among wild mice and segregates during inbreeding (1979) (205)
Nuclear-cytoplasmic shuttling of Axin regulates subcellular localization of beta-catenin. (2004) (199)
DNA bending creates favored sites for retroviral integration: an explanation for preferred insertion sites in nucleosomes. (1994) (197)
Glucocorticoid-stimulated accumulation of mouse mammary tumor virus RNA: increased rate of synthesis of viral RNA. (1977) (192)
The size and genetic composition of virus-specific RNAs in the cytoplasm of cells producing avian sarcoma-leukosis viruses (1977) (192)
Mitosis-specific phosphorylation of p60c-src by p34 cdc2-associated protein kinase (1989) (190)
Location and function of retroviral and SV40 sequences that enhance biochemical transformation after microinjection of DNA (1983) (188)
The erythroid cells and haemoglobins of the chick embryo. (1973) (187)
Isolation of a chicken gene that confers susceptibility to infection by subgroup A avian leukosis and sarcoma viruses (1993) (186)
Why PLoS Became a Publisher (2003) (185)
The purified product of the transforming gene of avian sarcoma virus phosphorylates tyrosine. (1980) (185)
Abnormal human haemoglobins. III. The chemical difference between normal and sickle cell haemoglobins. (1959) (183)
Potent inhibition of huntingtin aggregation and cytotoxicity by a disulfide bond-free single-domain intracellular antibody. (2004) (183)
Integration of the DNA of mouse mammary tumor virus in virus-infected normal and neoplastic tissue of the mouse (1979) (178)
Proposal for Naming Host Cell-Derived Inserts in Retrovirus Genomes (1981) (178)
Two proto-oncogenes implicated in mammary carcinogenesis, int-1 and int-2, are independently regulated during mouse development. (1986) (173)
Site-directed mutagenesis of HIV-1 integrase demonstrates differential effects on integrase functions in vitro. (1993) (173)
A retrovirus vector expressing the putative mammary oncogene int-1 causes partial transformation of a mammary epithelial cell line (1986) (172)
Enhanced: The Need for a Global HIV Vaccine Enterprise (2003) (169)
Two efficient ribosomal frameshifting events are required for synthesis of mouse mammary tumor virus gag-related polyproteins. (1987) (169)
Human immunodeficiency virus type 1 gag-pol frameshifting is dependent on downstream mRNA secondary structure: demonstration by expression in vivo (1992) (166)
Development of a flexible and specific gene delivery system for production of murine tumor models (1999) (165)
Regulation of Wnt signaling by Sox proteins: XSox17 alpha/beta and XSox3 physically interact with beta-catenin. (1999) (164)
The preS1 protein of hepatitis B virus is acylated at its amino terminus with myristic acid (1987) (163)
Telomerase activation in mouse mammary tumors: lack of detectable telomere shortening and evidence for regulation of telomerase RNA with cell proliferation (1996) (161)
Effect of n-Butyrate on DNA synthesis in chick fibroblasts and HeLa cells (1977) (159)
A mutant murine leukemia virus with a single missense codon in pol is defective in a function affecting integration. (1984) (159)
Gene deletion as the cause of α thalassaemia: Genetic lesion in homozygous α thalassaemia (hydrops fetalis) (1974) (158)
Expression of the precore region of an avian hepatitis B virus is not required for viral replication (1987) (158)
A small region of the mouse mammary tumor virus long terminal repeat confers glucocorticoid hormone regulation on a linked heterologous gene. (1983) (157)
Hemoglobin synthesis during amphibian metamorphosis. I. Chemical studies on the hemoglobins from the larval and adult stages of Rana catesbeiana. (1968) (155)
A joint product of the genes gag and pol of Avian Sarcoma Virus: a possible precursor of reverse transcriptase (1977) (154)
Transduction of a cellular oncogene: the genesis of Rous sarcoma virus. (1983) (153)
An RNA pseudoknot and an optimal heptameric shift site are required for highly efficient ribosomal frameshifting on a retroviral messenger RNA. (1992) (153)
Genetic Basis of the Thalassæmia Diseases (1959) (152)
Lung cancer signatures in plasma based on proteome profiling of mouse tumor models. (2011) (152)
Transcription of mouse mammary tumor virus genes in tissues from high and low tumor incidence mouse strains. (1973) (152)
The int-1 proto-oncogene products are glycoproteins that appear to enter the secretory pathway. (1987) (151)
Bethesda Statement on Open Access Publishing (2003) (149)
Reduced NF1 expression confers resistance to EGFR inhibition in lung cancer. (2014) (148)
The mouse Wnt-1 gene can act via a paracrine mechanism in transformation of mammary epithelial cells. (1992) (147)
Retroviral integration into minichromosomes in vitro. (1992) (147)
Expression of v-src and chicken c-src in rat cells demonstrates qualitative differences between pp60 v-src and pp60 c-src (1984) (146)
Structural studies on chick embryonic hemoglobins. (1974) (145)
Production of mouse mammary tumor virus by cultured cells in the absence and presence of hormones: assay by molecular hybridization. (1975) (143)
Wnt/Wingless signaling through β-catenin requires the function of both LRP/Arrow and frizzled classes of receptors (2003) (143)
Efficient reversal of Alzheimer's disease fibril formation and elimination of neurotoxicity by a small molecule. (2004) (143)
The evolution of a protein. (1962) (141)
A Mouse Mammary Tumor Virus-Wnt-1 Transgene Induces Mammary Gland Hyperplasia and Tumorigenesis in Mice Lacking Estrogen Receptor-α (1999) (139)
A system for tissue-specific gene targeting: transgenic mice susceptible to subgroup A avian leukosis virus-based retroviral vectors. (1994) (139)
Transgenes expressing the Wnt-1 and int-2 proto-oncogenes cooperate during mammary carcinogenesis in doubly transgenic mice. (1992) (138)
Two novel kinases phosphorylate tau and the KSP site of heavy neurofilament subunits in high stoichiometric ratios (1991) (137)
Mouse mammary tumor virus infection accelerates mammary carcinogenesis in Wnt-1 transgenic mice by insertional activation of int-2/Fgf-3 and hst/Fgf-4. (1993) (135)
Modeling mutations in the G1 arrest pathway in human gliomas: overexpression of CDK4 but not loss of INK4a-ARF induces hyperploidy in cultured mouse astrocytes. (1998) (133)
Biosynthesis of the reverse transcriptase of hepatitis B viruses involves de novo translational initiation not ribosomal frameshifting (1989) (133)
Deletion of α-globin genes in haemoglobin-H disease demonstrates multiple α-globin structural loci (1975) (133)
Casein Kinase Iε Modulates the Signaling Specificities of Dishevelled (2004) (132)
Regulation of inducible enzyme synthesis in Escherichia coli by cyclic adenosine 3', 5'-monophosphate. (1969) (132)
Mapping of linear and circular forms of mouse mammary tumor virus DNA with restriction endonucleases: evidence for a large specific deletion occurring at high frequency during circularization. (1978) (130)
Compromised mitochondrial function leads to increased cytosolic calcium and to activation of MAP kinases. (1997) (130)
Nucleotide sequencing of an apparent proviral copy of env mRNA defines determinants of expression of the mouse mammary tumor virus env gene (1983) (128)
The first seven amino acids encoded by the v-src oncogene act as a myristylation signal: lysine 7 is a critical determinant. (1988) (128)
Oncogene cooperation in tumor maintenance and tumor recurrence in mouse mammary tumors induced by Myc and mutant Kras (2008) (127)
Wild-type p53 transgenic mice exhibit altered differentiation of the ureteric bud and possess small kidneys. (1996) (126)
Nucleotide sequence of an infectious molecularly cloned genome of ground squirrel hepatitis virus (1984) (126)
Heterogeneity of genetic loci in chickens: analysis of endogenous viral and nonviral genes by cleavage of DNA with restriction endonucleases (1979) (124)
Regulation of HIV and HTLV gene expression. (1988) (124)
Mammary tumour virus specific nucleotide sequences in mouse DNA. (1972) (123)
Detection of avian tumor virus-specific nucleotide sequences in avian cell DNAs (reassociation kinetics-RNA tumor viruses-gas antigen-Rous sarcoma virus, chick cells). (1972) (123)
Overview of the Alliance for Cellular Signaling (2002) (122)
Binding of the Src SH2 domain to phosphopeptides is determined by residues in both the SH2 domain and the phosphopeptides. (1993) (121)
Mutational analysis of mouse Wnt-1 identifies two temperature-sensitive alleles and attributes of Wnt-1 protein essential for transformation of a mammary cell line. (1992) (121)
9 Functions and Origins of Retroviral Transforming Genes (1982) (121)
Deficiency of the Hck and Src tyrosine kinases results in extreme levels of extramedullary hematopoiesis. (1996) (120)
Methylation patterns of HeLa cell ribosomal RNA and its nucleolar precursors (1967) (120)
Brain protein kinase PK40erk converts TAU into a PHF-like form as found in Alzheimer's disease. (1993) (120)
Ethidium bromide inhibits appearance of closed circular viral DNA and integration of virus-specific DNA in duck cells infected by avian sarcoma virus (1975) (119)
Comparison of mouse mammary tumor virus-specific DNA in inbred, wild and Asian mice, and in tumors and normal organs from inbred mice. (1977) (119)
Integration of Deoxyribonucleic Acid Specific for Rous Sarcoma Virus after Infection of Permissive and Nonpermissive Hosts (1973) (117)
Mutational landscape of EGFR-, MYC-, and Kras-driven genetically engineered mouse models of lung adenocarcinoma (2016) (116)
The Absence of p53 Promotes Metastasis in a Novel Somatic Mouse Model for Hepatocellular Carcinoma (2005) (115)
Comparisons of tyrosine phosphorylated proteins in cells expressing lung cancer-specific alleles of EGFR and KRAS (2008) (115)
Kinetics of synthesis, structure and purification of avian sarcoma virus-specific DNA made in the cytoplasm of acutely infected cells. (1978) (114)
Evidence that synthetic lethality underlies the mutual exclusivity of oncogenic KRAS and EGFR mutations in lung adenocarcinoma (2015) (113)
Effects of insertional and point mutations on the functions of the duck hepatitis B virus polymerase (1990) (112)
Hormonal regulation of the rous sarcoma virus src gene via a heterologous promoter defines a threshold dose for cellular transformation (1984) (112)
The src protein contains multiple domains for specific attachment to membranes. (1990) (112)
MYC-induced myeloid leukemogenesis is accelerated by all six members of the antiapoptotic BCL family (2009) (112)
The c-myc and PyMT oncogenes induce different tumor types in a somatic mouse model for pancreatic cancer. (2003) (110)
Both substrate and target oligonucleotide sequences affect in vitro integration mediated by human immunodeficiency virus type 1 integrase protein produced in Saccharomyces cerevisiae (1992) (109)
Superoxide dismutase 1 (SOD1) is a target for a small molecule identified in a screen for inhibitors of the growth of lung adenocarcinoma cell lines (2011) (109)
Introduction of oncogenes into mammary glands in vivo with an avian retroviral vector initiates and promotes carcinogenesis in mouse models (2006) (108)
Genetic evidence for a role for Src family kinases in TNF family receptor signaling and cell survival. (2001) (107)
Development of a human light chain variable domain (V(L)) intracellular antibody specific for the amino terminus of huntingtin via yeast surface display. (2004) (107)
Genes and the Biology of Cancer (1995) (106)
Virus-specific DNA in the cytoplasm of avian sarcoma virus-infected cells is a precursor to covalently closed circular viral DNA in the nucleus (1978) (105)
Efficient incorporation of human CD4 protein into avian leukosis virus particles. (1990) (105)
Appearance of virus-specific DNA in mammalian cells following transformation by Rous sarcoma virus. (1973) (104)
Mapping the major transcripts of ground squirrel hepatitis virus: the presumptive template for reverse transcriptase is terminally redundant (1985) (104)
Corrections to the nucleotide sequence of the src gene of Rous sarcoma virus (1983) (103)
Structural and functional studies of retroviral RNA pseudoknots involved in ribosomal frameshifting: nucleotides at the junction of the two stems are important for efficient ribosomal frameshifting. (1995) (103)
Nucleotide sequence of cloned unintegrated avian sarcoma virus DNA: viral DNA contains direct and inverted repeats similar to those in transposable elements. (1981) (102)
Augmented expression of normal c-myc is sufficient for cotransformation of rat embryo cells with a mutant ras gene. (1985) (102)
Identification of genes from pattern formation, tyrosine kinase, and potassium channel families by DNA amplification. (1989) (101)
A characteristic bent conformation of RNA pseudoknots promotes -1 frameshifting during translation of retroviral RNA. (1996) (99)
RNA-directed DNA synthesis by virions of Rous sarcoma virus: further characterization of the templates and the extent of their transcription. (1973) (99)
Uninfected avian cells contain RNA related to the transforming gene of avian sarcoma viruses (1978) (97)
The Interactions of Retroviruses and their Hosts (1997) (96)
Nucleotide sequence and expression in vitro of cDNA derived from mRNA of int-1, a provirally activated mouse mammary oncogene. (1985) (96)
Site-directed mutagenesis of the SH2- and SH3-coding domains of c-src produces varied phenotypes, including oncogenic activation of p60c-src. (1990) (95)
Integration and transcription of mouse mammary tumor virus DNA in rat hepatoma cells. (1979) (94)
Cellular homologue (c-src) of the transforming gene of Rous sarcoma virus: isolation, mapping, and transcriptional analysis of c-src and flanking regions. (1981) (93)
Embryonic Red Blood Cell Formation (1972) (91)
Organization of mouse mammary tumor virus-specific DNA endogenous to BALB/c mice (1979) (90)
rlk/TXK Encodes Two Forms of a Novel Cysteine String Tyrosine Kinase Activated by Src Family Kinases (1999) (90)
5 Replication of Retroviruses (1982) (89)
Deficiency of Pten accelerates mammary oncogenesis in MMTV-Wnt-1 transgenic mice (2000) (89)
Differentiation of two mouse cell lines is associated with hypomethylation of their genomes. (1984) (88)
Allelomorphism and the Chemical Differences of the Human Hæmoglobins A, S and C (1958) (88)
Construction of a clonable, infectious, and tumorigenic mouse mammary tumor virus provirus and a derivative genetic vector. (1988) (87)
Closed circular viral DNA and asymmetrical heterogeneous forms in livers from animals infected with ground squirrel hepatitis virus (1983) (87)
Structure of viral DNA and RNA in mammalian cells infected with avian sarcoma virus. (1980) (87)
Two cellular proteins that immunoprecipitate with the transforming protein of Rous sarcoma virus. (1981) (86)
Ten years on--the human genome and medicine. (2010) (86)
Regulation of lac mRNA synthesis in a soluble cell-free system. (1971) (86)
Fv-1 restriction and its effects on murine leukemia virus integration in vivo and in vitro (1992) (85)
Mutational Analysis of EGFR and Related Signaling Pathway Genes in Lung Adenocarcinomas Identifies a Novel Somatic Kinase Domain Mutation in FGFR4 (2007) (85)
Synthesis of viral DNA in the cytoplasm of duck embryo fibroblasts and in enucleated cells after infection by avian sarcoma virus. (1974) (85)
Casein kinase Iepsilon modulates the signaling specificities of dishevelled. (2004) (85)
Development of an Avian Leukosis-Sarcoma Virus Subgroup A Pseudotyped Lentiviral Vector (2001) (83)
Organization of the endogenous proviruses of chickens: implications for origin and expression. (1981) (80)
The vertebrate homolog of the putative transforming gene of avian myelocytomatosis virus: characteristics of the DNA locus and its RNA transcript. (1980) (79)
The Molecular Biology of RNA Tumor Viruses (1975) (79)
Proviral deletions and oncogene base-substitutions in insertionally mutagenized c-myc alleles may contribute to the progression of avian bursal tumors. (1984) (78)
Identification of protein products encoded by the proto-oncogene int-1. (1987) (78)
Transcription of the hepatitis B surface antigen gene in cultured murine cells initiates within the presurface region (1984) (78)
Hemoglobin synthesis during amphibian metamorphosis. II. Synthesis of adult hemoglobin following thyroxine administration. (1968) (77)
Revertants of an ASV-transformed rat cell line have lost the complete provius or sustained mutations in src. (1981) (77)
Isolation of duplicated human c-src genes located on chromosomes 1 and 20. (1985) (76)
Getting ready for gene-based medicine. (2002) (76)
5'-terminal sequences influence the segregation of ground squirrel hepatitis virus RNAs into polyribosomes and viral core particles (1987) (75)
Sulphydryl groups in haemoglobins. (1955) (74)
Extent of transcription by the RNA-dependent DNA polymerase of Rous sarcoma virus. (1971) (74)
Peptide chain synthesis of human hemoglobins A and A2. (1966) (73)
Abnormal human haemoglobins. V. Chemical investigation of haemoglobins A, G, C, X from one individual. (1961) (73)
Oncogenes and transcriptional control. (1987) (73)
Characteristics of cellular RNA related to the transforming gene of avian sarcoma viruses (1978) (73)
Chemical Studies on Amino Acid Acceptor Ribonucleic Acids.*I. Some Properties of Yeast Amino Acid Acceptor Ribonucleic Acid and Mapping of the Oligonucleotides Produced by Ribonuclease Digestion (1962) (72)
The structure and protein kinase activity of proteins encoded by nonconditional mutants and back mutants in the sec gene of avian sarcoma virus. (1981) (72)
Mutations in src homology regions 2 and 3 of activated chicken c-src that result in preferential transformation of mouse or chicken cells. (1990) (71)
Synthesis, structure and function of avian sarcoma virus-specific DNA in permissive and nonpermissive cells. (1975) (71)
Erlotinib resistance in mouse models of epidermal growth factor receptor-induced lung adenocarcinoma (2010) (71)
Requirement for a Nuclear Function of β-Catenin in Wnt Signaling (2003) (71)
The repression and induction by thyroxin of hemoglobin synthesis during amphibian metamorphosis. (1965) (71)
A protein knockdown strategy to study the function of β-catenin in tumorigenesis (2003) (69)
Assessing Tumor Progression Factors by Somatic Gene Transfer into a Mouse Model: Bcl-xL Promotes Islet Tumor Cell Invasion (2007) (69)
Simian virus 40 minichromosomes as targets for retroviral integration in vivo. (1992) (68)
Amplification and enhanced expression of the c-myc oncogene in mouse SEWA tumour cells (1985) (67)
Demonstration of a DNA provirus in the lytic growth of visna virus. (1973) (67)
Ubiquitination, localization, and stability of an anti-apoptotic BCL2-like protein, BCL2L10/BCLb, are regulated by Ubiquilin1 (2012) (67)
Infection of cultured rat hepatoma cells by mouse mammary tumor virus (1977) (66)
The receptor for the subgroup A avian leukosis-sarcoma viruses binds to subgroup A but not to subgroup C envelope glycoprotein (1994) (66)
Regulation of transgenes in three-dimensional cultures of primary mouse mammary cells demonstrates oncogene dependence and identifies cells that survive deinduction. (2009) (66)
Proviruses of mouse mammary tumor virus in normal and neoplastic tissues from GR and C3Hf mouse strains (1980) (65)
Wild-Type U2AF1 Antagonizes the Splicing Program Characteristic of U2AF1-Mutant Tumors and Is Required for Cell Survival (2016) (64)
Chicken macrochromosomes contain an endogenous provirus and microchromosomes contain sequences related to the transforming gene of ASV (1977) (63)
A comparative evaluation of β-catenin and plakoglobin signaling activity (2000) (63)
A Rous sarcoma virus provirus is flanked by short direct repeats of a cellular DNA sequence present in only one copy prior to integration. (1981) (62)
Abnormal human haemoglobins. IV. The chemical difference between normal human haemoglobin and haemoglobin C. (1960) (62)
Genetic lesion in homozygous alpha thalassaemia (hydrops fetalis). (1974) (61)
A mouse mammary tumor virus-Wnt-1 transgene induces mammary gland hyperplasia and tumorigenesis in mice lacking estrogen receptor-alpha. (1999) (60)
Mechanism of membrane depolarization caused by the Alzheimer Abeta1-42 peptide. (2002) (60)
Mechanism and prevention of neurotoxicity caused by β-amyloid peptides: relation to Alzheimer's disease (1997) (60)
Stochastic kinetics of intracellular huntingtin aggregate formation (2006) (60)
Gene localization by chromosome fractionation: globin genes are on at least two chromosomes and three estrogen-inducible genes are on three chromosomes. (1979) (60)
Unintegrated viral DNA is synthesized in the cytoplasm of avian sarcoma virus-transformed duck cells by viral DNA polymerase (1976) (59)
Aggregates of a β-amyloid peptide are required to induce calcium currents in neuron-like human teratocarcinoma cells: relation to Alzheimer's disease (1997) (58)
The action of fluorodinitrobenzene on bacterial cell walls. (1957) (58)
A Terminal Peptide Sequence of Human Hæmoglobin? (1959) (58)
The cloned genome of ground squirrel hepatitis virus is infectious in the animal. (1984) (58)
Homologies among the nucleotide sequences of the genomes of C-type viruses. (1974) (58)
Direct and selective elimination of specific prions and amyloids by 4,5-dianilinophthalimide and analogs (2008) (57)
Demonstration of non-functional beta-globin mRNA in homozygous beta (0) thalassemia. (1975) (57)
Diversity among Purkinje cells in the monkey cerebellum. (1985) (57)
Erythrocyte Transfer RNA: Change during Chick Development (1967) (57)
The leader sequence of the subgenomic mRNA's of Rous sarcoma virus is approximately 390 nucleotides (1982) (57)
Use of avian retroviral vectors to introduce transcriptional regulators into mammalian cells for analyses of tumor maintenance (2003) (56)
Woodchuck hepatitis virus is a more efficient oncogenic agent than ground squirrel hepatitis virus in a common host (1991) (56)
A frameshift mutation in the pre-S region of the human hepatitis B virus genome allows production of surface antigen particles but eliminates binding to polymerized albumin. (1985) (55)
Chemistry of the abnormal human haemoglobins. (1959) (55)
Human haemoglobin A2: I. Comparison of haemoglobins A2 and A (1962) (55)
Membrane-anchored plakoglobins have multiple mechanisms of action in Wnt signaling. (1999) (55)
Absence of p53 in a mouse mammary tumor model promotes tumor cell proliferation without affecting apoptosis. (1997) (55)
Identification of a provirally activated c‐Ha‐ras oncogene in an avian nephroblastoma via a novel procedure: cDNA cloning of a chimaeric viral‐host transcript. (1986) (55)
Frameshift and intragenic suppressor mutations in a rous sarcoma provirus suggest src encodes two proteins (1983) (55)
ERYTHROPOIESIS DURING AMPHIBIAN METAMORPHOSIS : III. Immunochemical Detection of Tadpole and Frog Hemoglobins (Rana catesbeiana) in Single Erythrocytes. (1971) (55)
Mouse mammary tumor virus DNA in infected rat cells: Characterization of unintegrated forms (1977) (55)
Virus-specific messenger RNAs in permissive cells infected by avian sarcoma virus. (1979) (54)
Abnormal human haemoglobins. VI. The chemical difference between haemoglobins A and E. (1961) (54)
Abnormal human haemoglobins. II. The chymotryptic digestion of the trypsin-resistant core of haemoglobins A and S. (1958) (54)
Human Hæmoglobin A2: Chemistry, Genetics and Evolution (1961) (53)
Mouse Mammary Tumors Express Elevated Levels of RNA Encoding the Murine Homolog of SKY, a Putative Receptor Tyrosine Kinase (*) (1995) (53)
Reverse transcription. (1987) (53)
Structural analysis of the intracellular RNAs of murine mammary tumor virus (1979) (53)
Differences in erythrocyte membrane proteins and glycoproteins in sickle cell disease. (1977) (52)
Use of DNA-DNA Annealing to Detect New Virus-Specific DNA Sequences in Chicken Embryo Fibroblasts After Infection by Avian Sarcoma Virus (1974) (52)
Detection and enumeration of transformation-defective strains of avian sarcoma virus with molecular hybridization. (1977) (52)
Evaluating the burden of disease and spending the research dollars of the National Institutes of Health. (1999) (52)
Evolution of somatic mutations in mammary tumors in transgenic mice is influenced by the inherited genotype (2004) (51)
Erythropoiesis in the developing chick embryo. (1973) (51)
Retrotransposons, Endogenous Retroviruses, and the Evolution of Retroelements -- Retroviruses (1997) (51)
Building A "GenBank" of the Published Literature (2001) (51)
Regulation of lac transcription in antibiotic-treated E. coli. (1971) (50)
The nucleotide sequence of an untranslated but conserved domain at the 3' end of the avian sarcoma virus genome (1980) (50)
Regulation of lac messenger ribonucleic acid synthesis by cyclic adenosine 3',5'-monophosphate and glucose. (1970) (50)
The National Institutes of Health and clinical research: a progress report (2000) (50)
At least 104 nucleotides are transposed from the 5′ terminus of the avian sarcoma virus genome to the 5′ termini of smaller viral mrnas (1978) (50)
Statement on Scientific Publication and Security (2003) (50)
Genetic basis of the thalassaemia diseases. (1959) (50)
Constituents of Human Hæmoglobin: Separation of the Peptide Chains of Human Globin (1959) (50)
The Wnt-1 proto-oncogene induces changes in morphology, gene expression, and growth factor responsiveness in PC12 cells (1993) (50)
Origin and function of avian retrovirus transforming genes. (1980) (49)
A mutation in v-src that removes a single conserved residue in the SH-2 domain of pp60v-src restricts transformation in a host-dependent manner (1989) (48)
The persistence and expression of virus-specific DNA in revertants of Rous sarcoma virus-transformed BHK-21 cells. (1974) (48)
Characteristics of virus-specific RNA in avian sarcoma virus-transformed BHK-21 cells and revertants. (1977) (48)
Requirements for activation and RAFT localization of the T-lymphocyte kinase Rlk/Txk (2001) (47)
Multiple alpha and beta tubulin genes represent unlinked and dispersed gene families. (1981) (47)
Loss of MIG6 Accelerates Initiation and Progression of Mutant Epidermal Growth Factor Receptor-Driven Lung Adenocarcinoma. (2015) (46)
Synthesis of plus strands of retroviral DNA in cells infected with avian sarcoma virus and mouse mammary tumor virus (1981) (46)
ERYTHROPOIETIC CELL CULTURES FROM CHICK EMBRYOS (1972) (46)
Changes in gene expression during the development of mammary tumors in MMTV-Wnt-1 transgenic mice (2005) (46)
Activity of Wnt-1 as a transmembrane protein. (1993) (45)
Receptor for hyaluronan-mediated motility isoform B promotes liver metastasis in a mouse model of multistep tumorigenesis and a tail vein assay for metastasis (2011) (45)
Synthesis, Assembly, and Processing of Viral Proteins -- Retroviruses (1997) (45)
Nucleotide sequence of the 5' noncoding region and part of the gag gene of Rous sarcoma virus (1982) (45)
Three Varieties of Human Hæmoglobin D (1958) (45)
Analysis of endogenous avian retrovirus DNA and RNA: viral and cellular determinants of retrovirus gene expression. (1981) (44)
ERYTHROPOIESIS DURING AMPHIBIAN METAMORPHOSIS : I. Site of Maturation of Erythrocytes in Rana catesbeiana. (1971) (44)
Opinion: Addressing systemic problems in the biomedical research enterprise (2015) (44)
Addressing the Growing International Challenge of Cancer: A Multinational Perspective (2013) (43)
Growth-dependent expression of multiple species of DNA methyltransferase in murine erythroleukemia cells. (1985) (42)
Use of alkaline sucrose gradients in a zonal rotor to detect integrated and unintegrated avian sarcoma virus-specific DNA in cells (1976) (42)
A genetic screen identifies cellular factors involved in retroviral -1 frameshifting. (1995) (42)
Mechanism of translation of the hepadnaviral polymerase (P) gene. (1990) (42)
Overexpression of the Sky receptor tyrosine kinase at the cell surface or in the cytoplasm results in ligand-independent activation. (1995) (42)
Generation of pulmonary neuroendocrine cells and SCLC-like tumors from human embryonic stem cells (2019) (42)
DEVELOPMENTAL CHANGES OF ERYTHROPOIESIS IN CULTURED CHICK BLASTODERMS (1971) (42)
Genetic Mapping of the Cloned Subgroup A Avian Sarcoma and Leukosis Virus Receptor Gene to the TVALocus (1998) (41)
Interaction of Wnt-1 proteins with the binding protein BiP. (1992) (41)
Characterization of DNA complementary to nucleotide sequences at the 5'-terminus of the avian sarcoma virus genome. (1977) (41)
Statement on the consideration of biodefence and biosecurity (2003) (40)
Ribonucleic acid directed deoxyribonucleic acid synthesis by the purified deoxyribonucleic acid polymerase of Rous sarcoma virus. Characterization of the enzymatic product. (1972) (40)
Recommendations for the nomenclature of hemoglobins. (1961) (40)
The terminal redundancy of the retrovirus genome facilitates chain elongation by reverse transcriptase. (1981) (40)
Stimulation of lac mRNA synthesis by cyclic AMP in cell free extracts of Escherichia coli. (1970) (40)
DNA methylation in chicken alpha-globin gene expression. (1982) (40)
Human immunodeficiency viruses [letter] (1986) (38)
Chemical Modification of Yeast Alanine-tRNA with a Radioactive Carbodiimide (1967) (38)
Virion DNA of ground squirrel hepatitis virus: structural analysis and molecular cloning (1982) (38)
Integrating Cancer Control into Global Health (2011) (37)
Characterization of DNA complementary to nucleotide sequences adjacent to poly(A) at the 3'-terminus of the avian sarcoma virus genome. (1977) (37)
Histones in chick embryonic erythropoiesis. (1973) (37)
Nucleotide sequence homologies among mouse mammary tumor viruses. (1976) (36)
Tadpole Antibodies against Frog Hemoglobin and Their Effect on Development (1969) (36)
Hyperphosphorylation of human TAU by brain kinase PK40erk beyond phosphorylation by cAMP-dependent PKA: relation to Alzheimer's disease. (1994) (36)
Two wnt genes in Caenorhabditis elegans. (1993) (36)
Persistence and expression of Marek's disease virus DNA in tumour cells and peripheral nerves studied by in situ hybridization. (1981) (36)
Oncogenes come of age. (2005) (36)
Amplification of N-myc sequences in primary human neuroblastomas: correlation with advanced disease stage. (1985) (36)
Regulation of mouse mammary tumor virus gene expression by glucocorticoid hormones. (1979) (36)
Requirement for a nuclear function of beta-catenin in Wnt signaling. (2003) (36)
Endogenous mouse mammary tumor virus DNA is distributed among multiple mouse chromosomes. (1979) (35)
Regulation of gal messenger ribonucleic acid synthesis in Escherichia coli by 3',5'-cyclic adenosine monophosphate. (1971) (35)
Hyperactivation of ERK by multiple mechanisms is toxic to RTK-RAS mutation-driven lung adenocarcinoma cells (2018) (35)
Human haemoglobin A2. II. The chemistry of some peptides peculiar to haemoglobin A2. (1962) (35)
Molecular biology: Reverse transcriptase rides again (1985) (34)
Impaired hematopoiesis and leukemia development in mice with a conditional knock-in allele of a mutant splicing factor gene U2af1 (2018) (34)
[E-Biomed: A Proposal for Electronic Publications in the Biomedical Sciences (Draft and Addendum)] (1999) (33)
Biological characterization of acute infection with ground squirrel hepatitis virus (1982) (33)
Purification and translation of murine mammary tumor virus mRNA's (1981) (33)
SYNTHESIS OF VIRAL RNA IN CELLS INFECTED BY AVIAN SARCOMA VIRUSES (1976) (33)
Purification of DNA complementary to the env gene of avian sarcoma virus and analysis of relationships among the env genes of avian leukosis-sarcoma viruses (1977) (32)
Reverse transcription in bacteria (1989) (32)
CHEMICAL STUDIES ON AMINO ACID ACCEPTOR RIBONUCLEIC ACIDS. II. ATTEMPTS AT PARTIAL DIGESTION OF YEAST AMINO ACID ACCEPTOR RIBONUCLEIC ACID WITH PANCREATIC RIBONUCLEASE. (1964) (32)
A comparative evaluation of beta-catenin and plakoglobin signaling activity. (2000) (31)
Retroviral Pathogenesis -- Retroviruses (1997) (31)
Nuclear protein synthesis and phosphorylation in Friend erythroleukemia cells stimulated with DMSO. (1978) (31)
In vitro recombinants of ground squirrel and woodchuck hepatitis viral DNAs produce infectious virus in squirrels (1987) (31)
Four Adult Hæmoglobin Types in One Person (1961) (31)
Hemoglobin and its Abnormalities (1961) (31)
Activation of a neurofilament kinase, a tau kinase, and a tau phosphatase by decreased ATP levels in nerve growth factor-differentiated PC-12 cells. (1995) (31)
Synthesis, structure, and integration of the DNA of RNA tumor viruses. (1979) (30)
DNA of Rous Sarcoma Virus: Its Nature and Significance (1972) (30)
ERYTHROPOIESIS DURING AMPHIBIAN METAMORPHOSIS : II. Immunochemical Study of Larval and Adult Hemoglobins of Rana catesbeiana. (1971) (30)
Retroviral Virions and Genomes -- Retroviruses (1997) (30)
Biosynthesis of macromolecules (1965) (29)
Antibodies to pre-S and X determinants arise during natural infection with ground squirrel hepatitis virus (1986) (29)
Synthesis of polymeric peptides in proteinase-catalyzed transamidation reactions. (1953) (29)
Sickle-Cell Anemia Hemoglobin: The Molecular Biology of the First “Molecular Disease”—The Crucial Importance of Serendipity (2004) (29)
Retroviruses and Oncogenes I (1990) (29)
Transcription of ribonucleic acid by the ribonucleic acid directed deoxyribonucleic acid polymerase of Rous sarcoma virus and deoxyribonucleic acid polymerase I of Escherichia coli. (1973) (29)
In vitro transcription of chromatin containing histones hyperacetylated in vivo. (1980) (29)
Dexamethasone Induction of the Intracellular RNAs of Mouse Mammary Tumor Virus (1981) (29)
Rearrangement at the 5' end of amplified c-myc in human COLO 320 cells is associated with abnormal transcription. (1986) (28)
Accelerating progress on non-communicable diseases (2013) (28)
Uncensored exchange of scientific results (2003) (28)
Integration of avian sarcoma virus DNA in chicken cells. (1981) (28)
Cancer genes and hematopoiesis. (1994) (27)
RNA aggregation during sulfhydryl-agarose chromatography of mercurated RNA. (1977) (27)
The Regulation of lac Operon Transcription by Cyclic Adenosine 3′, 5′-Monophosphate (1970) (27)
Abnormal Human Hæmoglobins: Human Hæmoglobin E: the Chemical Effect of Gene Mutation (1959) (26)
YES1 amplification is a mechanism of acquired resistance to EGFR inhibitors identified by transposon mutagenesis and clinical genomics (2018) (26)
Proteins and glycoproteins of membranes from developing chick red cells. (1976) (26)
Differentiation in the early chick embryo: effects of bromodeoxyuridine on erythropoiesis. (1974) (26)
Alfred P. Sloan prize. Viruses, genes, and cancer. I. The discovery of cellular oncogenes and their role in neoplasia (1985) (25)
Hyperphosphorylation of the cytoskeletal protein Tau by the MAP-kinase PK40erk2: regulation by prior phosphorylation with cAMP-dependent protein kinase A. (1995) (25)
Reverse Transcriptase and the Generation of Retroviral DNA -- Retroviruses (1997) (25)
Mutants of Rous sarcoma virus with extensive deletions of the viral genome. (1979) (25)
The spirit of Dakar: a call for action on malaria (1997) (25)
Hemoglobin synthesis at elevated temperatures. (1972) (25)
CHEMICAL STUDIES ON AMINO ACID ACCEPTOR RIBONUCLEIC ACIDS. 3. THE DEGRADATION OF PURIFIED ALANINE- AND VALINE-SPECIFIC YEAST S-RNA'S BY PANCREATIC RIBONUCLEASE. (1964) (25)
Extrachromosomal DNA forms of copia-like transposable elements, F elements and middle repetitive DNA sequences in Drosophila melanogaster. Variation in cultured cells and embryos. (1985) (25)
Reaction of 5 s RNA with a radioactive carbodiimide. (1969) (25)
Atomic force microscopy analysis of the Huntington protein nanofibril formation. (2005) (24)
Differences between genomes of two strains of mouse mammary tumor virus as shown by partial RNA sequence analysis. (1976) (24)
Retroviral DNA integrated during infection by an integration-deficient mutant of murine leukemia virus is oligomeric (1987) (24)
Science funding: Provocative questions in cancer research (2012) (24)
Gene evolution in the chicken β-globin cluster (1982) (24)
Characterization of "early" temperature-sensitive mutants of avian sarcoma viruses: biological properties, thermolability of reverse transcriptase in vitro, and synthesis of viral DNA in infected cells. (1976) (24)
Acetylated peptide chains in bullfrog hemoglobins. (1967) (24)
Identification and Preliminary Characterization of Novel Small Molecules That Inhibit Growth of Human Lung Adenocarcinoma Cells (2009) (23)
Production of p60c-src by baculovirus expression and immunoaffinity purification. (1991) (23)
Recent Evidence for Oncogenesis by Insertion Mutagenesis and Gene Activation (1982) (23)
The identification of peptide end-groups as dimethylamino acids. (1953) (23)
Integration and expression of several molecular forms of Rous sarcoma virus DNA used for transfection of mouse cells. (1984) (23)
Chemical studies on amino acid acceptor ribonucleic acids. IV. Position of the amino acid residue in aminoacyl srna; chemical approach. (1965) (23)
The role of p53 loss in genomic instability and tumor progression in a murine mammary cancer model. (1996) (23)
Aggregates of a beta-amyloid peptide are required to induce calcium currents in neuron-like human teratocarcinoma cells: relation to Alzheimer's disease. (1997) (23)
Atomic force microscopy analysis of the Huntington protein nanofibril formation. (2005) (22)
SH2 mutants of c-src that are host dependent for transformation are trans-dominant inhibitors of mouse cell transformation by activated c-src. (1990) (21)
Identification of a human gene (HCK) that encodes a protein-tyrosine kinase and is expressed in hemopoietic cells (1987) (21)
Biochemical mechanisms of oncogene activity: proteins encoded by oncogenes. Introduction. (1986) (21)
Transmission of ground squirrel hepatitis virus to homologous and heterologous hosts (1985) (21)
The importance of DNA size for successful transfection of chicken embryo fibroblasts. (1974) (21)
ERBB3-independent activation of the PI3K pathway in EGFR-mutant lung adenocarcinomas. (2015) (21)
Regulation of lac transcription in Escherichia coli by cyclic adenosine 3',5'-monophosphate. Studies with deoxyribonucleic acid-ribonucleic acid hybridization and hybridization competition. (1970) (20)
DOK2 Inhibits EGFR-Mutated Lung Adenocarcinoma (2013) (20)
Restriction endonuclease mapping of the DNA of Rous-associated virus O reveals extensive homology in structure and sequence with avian sarcoma virus DNA. (1981) (20)
Mechanism and prevention of neurotoxicity caused by beta-amyloid peptides: relation to Alzheimer's disease. (1997) (20)
Constituents of Human Hæmoglobin: Comparison of Normal Adult Human Hæmoglobin with Hæmoglobin I by ‘Fingerprinting’ (1959) (20)
Shattuck Lecture--biomedical research enters the steady state. (1995) (19)
Ca(2+), within the physiological concentrations, selectively accelerates Abeta42 fibril formation and not Abeta40 in vitro. (2009) (19)
Isolation and transformation of primary mesenchymal cells of the chick embryo (1979) (19)
Genesis of a virus-transforming gene. (1978) (19)
1 An Historical Overview of Oncogenes (1989) (18)
CHAPTER 10 – Retroviruses (1983) (18)
env Gene of Chicken RNA Tumor Viruses: Extent of Conservation in Cellular and Viral Genomes (1978) (18)
Chemical studies on amino acid acceptor ribonucleic acids. VI. Partial digestion of alanine soluble ribonucleic acid from yeast with pancreatic ribonuclease. (1966) (18)
Regulation of specific gene expression during embryonic development: Synthesis of globin messenger RNA during red cell formation in chick embryos. (1974) (18)
[118] Sequence methods☆ (1963) (18)
Function, location, and regulation of the src protein-tyrosine kinase. (1989) (18)
Insurance for broad genomic tests in oncology (2017) (18)
Viral Entry and Receptors -- Retroviruses (1997) (18)
CULTURE OF ERYTHROPOIETIC CELLS FROM CHICK BLASTODERMS (1973) (18)
Features of the chicken c-myc gene that influence the structure of c-myc RNA in normal cells and bursal lymphomas. (1986) (17)
Isoelectric Point of Chymotrypsinogen by a Donnan Equilibrium Method (1952) (17)
DISTRIBUTION AND FUNCTION OF DEFINED REGIONS OF AVIAN TUMOR VIRUS GENOMES IN VIRUSES AND UNINFECTED CELLS (1976) (17)
Biological and biochemical studies on the inactivation of avian oncoviruses by ultraviolet irradiation. (1977) (17)
How do Genes Act (1958) (17)
Detection of antibodies against hepatitis B virus polymerase antigen in hepatitis B virus‐infected patients (1989) (17)
Nucleosome-associated proteins and phosphoproteins of differentiating Friend erythroleukemia cells. (1978) (17)
Chemical studies on amino acid acceptor ribonucleic acids. VII. Partial ribonuclease digestion of alanine and valine soluble ribonucleic acid from yeast. (1966) (17)
Stimulation of heme accumulation and erythroid colony formation in cultures of chick bone marrow cells by chicken plasma (1978) (17)
Factors affecting phenotypic reversion of rat cells transformed by avian sarcoma virus. (1980) (17)
Studies on the Structure of Purified Alanine and Valine Transfer RNA from Yeast (1963) (17)
The Interactions of Retroviruses and their Hosts -- Retroviruses (1997) (17)
Evolution of karyotypic abnormalities and C-MYC oncogene amplification in human colonic carcinoma cell lines (2004) (16)
Structure of a replication intermediate in the synthesis of Rous sarcoma virus DNA in vivo (1982) (16)
Endogenous proviruses of random-bred chickens and ring-necked pheasants: analysis with restriction endonucleases. (1981) (16)
Homologous recombination between hepadnaviral genomes following in vivo DNA transfection: implications for studies of viral infectivity. (1987) (16)
Detection and characterization of RNA tumor virus-specific DNA in cells. (1975) (16)
Genomic empowerment: the importance of public databases (2003) (16)
A Molecular Model for Thalassemia * (1964) (16)
RNA viruses: Reverse transcription in plants? (1983) (16)
How Cancer Genomics Drives Cancer Biology: Does Synthetic Lethality Explain Mutually Exclusive Oncogenic Mutations? (2016) (15)
The genesis of Rous sarcoma virus messenger RNAs. (1981) (15)
Identification of a novel casein kinase activity in HeLa cell nuclei. (1989) (15)
Eliminating membrane depolarization caused by the Alzheimer peptide Abeta(1-42, aggr.). (2002) (15)
DNA intermediates in the replication of retroviruses are structurally (and perhaps functionally) related to transposable elements. (1981) (15)
Identification of ovotransferrin as a heme-, colony- and burst-stimulating factor in chick erythroid cell cultures. (1981) (14)
Elimination of Amyloid β Neurotoxicity (2000) (14)
Characterization of the nucleic acid product of the visna virus RNA dependent DNA polymerase. (1974) (14)
Harvard University Commencement Address (1996) (14)
The impact of physics on biology and medicine (1999) (14)
Of birds and mice and men: Comments on the use of animal models and molecular hybridization in the search for human tumor viruses (1974) (14)
RNA complementary to the genome of RNA tumor viruses in virions and virus-producing cells (1976) (13)
Activation of PyMT in β Cells Induces Irreversible Hyperplasia, but Oncogene-Dependent Acinar Cell Carcinomas When Activated in Pancreatic Progenitors (2009) (13)
Change in a nuclear phosphoprotein during in vitro myogenesis. (1978) (13)
Aminoacyl Position in Aminoacyl sRNA (1964) (13)
The sulphydryl groups of sickle-cell haemoglobin. (1957) (13)
Identification and characterization of dimeric and trimeric circular forms of avian sarcoma virus-specific DNA. (1980) (13)
Abnormal human haemoglobins. VII. The comparison of normal human haemoglobin and haemoglobin D-Chicago. (1961) (13)
Ontogeny of hemoglobins: evidence for hemoglobin M. (1974) (13)
Reverse transcriptase rides again. (1985) (12)
Genetic Control of Fœtal and Adult Human Hæmoglobin (1961) (12)
A Micro End-Group Method for Peptides (1950) (12)
Nucleosome-associated protein kinases in murine erythroleukemia cells. (1979) (12)
Is there specific transcription from isolated chromatin? (1978) (12)
Deletion of alpha-globin genes in haemoglobin-H disease demonstrates multiple alpha-globin structural loci. (1975) (11)
Concrete steps to diversify the scientific workforce (2021) (11)
Statement of Harold Varmus, MD, Director, National Institutes of Health, before the Senate Appropriations Subcommittee on Labor, Health and Human Services, Education and Related Agencies (1998) (11)
Using retroviruses as insertional mutagens to identify cellular oncogenes. (1983) (11)
Support for the Human Cancer Genome Project (2005) (11)
CONTROL MECHANISMS IN HEMOGLOBIN SYNTHESIS (1966) (10)
Autolysis Products of Pepsin (1951) (10)
The presence and expression of RNA tumor virus genes in normal and infected cells: detection by molecular hybridization. (1973) (10)
The Place of Retroviruses in Biology (1997) (10)
LEARNING ABOUT THE REPLICATION OF RETROVIRUSES FROM A SINGLE CLONED PROVIRUS OF MOUSE MAMMARY TUMOR VIRUS (1980) (10)
Erratum: The Classic: Integration of Deoxyribonucleic Acid Specific for Rous Sarcoma Virus after Infection of Permissive and Nonpermissive Hosts (1973) (10)
Elimination of Amyloid beta Neurotoxicity. (2000) (10)
Principles of Retroviral Vector Design (1997) (10)
A growing role for reverse transcription (1982) (10)
Electrophoresis: an accident and some precautions. (1966) (9)
Chemical studies on amino acid acceptor ribonucleic acids. 8. Degradation of purified alanine Escherichia coli B transfer ribonucleic acid by pancreatic ribonuclease. (1969) (9)
cDNA sequence of a new chicken embryonic rho-globin. (1981) (9)
Synthesis and Processing of Viral RNA -- Retroviruses (1997) (9)
Wild-type U2AF1 antagonizes the splicing program characteristic of U2AF1-mutant tumors and is required for cell survival (2016) (9)
Re-Aim Blame for NIH's Hard Times (2006) (9)
Tau domains, phosphorylation, and interaction with microtubules (1995) (9)
PLoS Medicine— A Medical Journal for the Internet Age (2004) (9)
Chemical modification of yeast alanine transfer ribonucleic acid with a radioactive carbodiimide. (1970) (9)
ERYTHROPOIESIS DURING AMPHIBIAN METAMORPHOSIS (1971) (9)
Proliferation of National Institutes of Health (2001) (9)
Modified histones in HeLa and Friend erythroleukemia cells treated with n-butyrate. (1978) (9)
Historical Introduction to the General Properties of Retroviruses -- Retroviruses (1997) (9)
Globin synthesis in fibroblasts fused with erythroblasts. I. avian fibroblasts (1975) (9)
ERRATUM: Glycogen synthase kinase-3 and dorsoventral patterning in Xenopus embryos (1995) (9)
The transformation of oncology (2016) (8)
Revitalization of the Warren G. Magnuson Clinical Center at the National Institutes of Health (1998) (8)
Nobel lecture. Retroviruses and oncogenes. I. (1990) (8)
Origins and Beginnings (2003) (8)
An active National Institute of Mental Health. (1995) (8)
Homogeneously staining chromosomal regions contain amplified copies of an abundantly expressed cellular oncogene ( c-mnc ) in malignant neuroendocrine cells from a human colon carcinoma ( double minute chromosomes / chromosome aberrations / retroviruses / tumorigenesis ) (8)
Improving support for young biomedical scientists (2018) (8)
Some Characteristics of Binding of Vitamin B12 by Normal Human Serum (1960) (8)
An aberrant avian leukosis virus provirus inserted downstream from the chicken c-myc coding sequence in a bursal lymphoma results from intrachromosomal recombination between two proviruses and deletion of cellular DNA (1987) (8)
Science and the new administration. (1993) (8)
Integration of avian sarcoma virus specific DNA in mammalian chromatin. (1975) (8)
DNA of a chicken herpesvirus is associated with at least two chromosomes in a chicken lymphoblastoid cell line. (1980) (8)
Amino acids in yeast acceptor ribonucleic acid (1962) (8)
Expression and partial DNA sequence of the chicken beta H-globin gene. (1983) (8)
Effect of phenylhydrazine-induced anemia on the appearance of adult hemoglobin in Rana catesbeiana tadpoles. (1972) (8)
Hemoglobin: Molecular Structure and Function, Biosynthesis, Evolution and Genetics. (1962) (8)
Cell-free translation of purified avian sarcoma virus src mRNA. (1981) (7)
Identification of protein products encoded by the proto-oncogene int-1 (1987) (7)
A prospective study to correlate EGFR mutations with gefitinib response (2005) (7)
The application of Edman's peptide degradation method to horse myoglobin and haemoglobin. (1955) (7)
Purification, Composition, and Morphology of Virions (1997) (7)
Science and the Control of AIDS (1998) (7)
Building a global culture of science (2002) (7)
The synthesis of macromolecules (1965) (7)
Retroviruses and Oncogenes I (Nobel Lecture) (1990) (7)
Detection of nucleotide sequences associated with transformation by avian sarcoma viruses. (1975) (7)
Defining the steps in a multistep mouse model for mammary carcinogenesis. (1994) (7)
Organization of endogenous and exogenous viral and linked nonviral sequences. (1980) (7)
Moloney murine leukemia virus integration protein produced in yeast binds specifically to viral att sites (1990) (7)
Hæmoglobin F and the Genetic Control of Protein Structure (1961) (7)
Genomic empowerment: the importance of public databases (2002) (7)
Tumor Viruses and Oncogenes (1973) (6)
Uncoupling of mitochondria activates protein phosphatases and inactivates MBP protein kinases. (2001) (6)
Development and Applications of Retroviral Vectors -- Retroviruses (1997) (6)
Lessons from the life cycle of retroviruses. (1987) (6)
ERYTHROID CELL DIFFERENTIATION AND THE INHIBITION OF CYTOKINESIS BY CYTOCHALASIN (1971) (6)
Biochemical genetics at the molecular level. (1963) (6)
Science as a Way of Thinking. (1996) (6)
DETERMINATION AND DIFFERENTIATION OF ERYTHROPOIESIS IN THE EARLY CHICK EMBRYO * (1974) (6)
Repair of lesions which cause premature termination of transcription in chicken embryo cells irradiated with ultraviolet light. (1981) (6)
The birth of molecular biology (2002) (6)
The impact of open access on biomedical research (2000) (6)
YES1 amplification as a mechanism of acquired resistance (AR) to EGFR tyrosine kinase inhibitors (TKIs) identified by a transposon mutagenesis screen and clinical genomic testing. (2017) (6)
Retroviral integration machinery as a probe for DNA structure and associated proteins. (1993) (6)
The int-1 proto-oncogene. (1986) (5)
Course of Infection with HIV and SIV (1997) (5)
The Pastorian: a legacy of Louis Pasteur. (1996) (5)
Harold Varmus [interview by Karen Birmingham]. (2001) (5)
Histones of chick embryonic lens nuclei. (1974) (5)
Readings in tumor virology (1983) (5)
Highly conserved amino acids in the SH2 and catalytic domains of v-src are altered in naturally occurring, transformation-defective alleles. (1994) (5)
How Tumor Virology Evolved into Cancer Biology and Transformed Oncology (2017) (5)
Definition of regions in human c-myc that are involved in transformation and nuclear localization (1987) (5)
Progenitor cells of the definitive erythroid series in the chick embryo. (1973) (5)
Naming the AIDS Virus (1986) (5)
NIH review of gene therapy protocols. (1995) (5)
Human haemoglobin E: the chemical effect of gene mutation. (1959) (4)
A simple screening procedure for hemoglobin S. (1973) (4)
Structure and variability of human chromosome ends (1990) (4)
Oncogenes and cell proliferation. (1993) (4)
THE ORIGIN AND STRUCTURE OF ENDOGENOUS RETROVIRAL DNA (1980) (4)
The replication of subgroup E avian retroviruses is blocked at or before viral DNA synthesis in restrictive chicken cells. (1979) (4)
The role of Alzheimer Abeta peptides in ion transport across cell membranes. (2005) (4)
Synthesis and Organization of Env Glycoproteins (1997) (4)
Pathogenesis of HIV and SIV -- Retroviruses (1997) (4)
Characteristics of the Transcription of RNA by the DNA Polymerase of Rous Sarcoma Virus (1973) (4)
Public-access group supports PubMed Central (2002) (4)
Mouse mammary tumor virus genes: regulation of expression by glucocorticoids and structural analysis with restriction endonucleases. (1978) (4)
The Classic: Integration of Deoxyribonucleic Acid Specific for Rous Sarcoma Virus after Infection of Permissive and Nonpermissive Hosts (2008) (4)
National Cancer Institute-supported clinical trials networks. (2015) (4)
Processing of Retroviral RNA (1997) (4)
Author response: Evidence that synthetic lethality underlies the mutual exclusivity of oncogenic KRAS and EGFR mutations in lung adenocarcinoma (2015) (4)
Varmus: the view from Bethesda. Interview by Eliot Marshall. (1993) (3)
Recommendations for the nomenclature of hemoglobins. (1961) (3)
Alzheimer tangles and abnormal phosphorylation. (1995) (3)
Overview of Reverse Transcription (1997) (3)
A Brief Chronicle of Retrovirology (1997) (3)
METHODS OF SEQUENCE ANALYSIS IN PROTEINS (1960) (3)
A tubulin identified by a monoclonal antibody is not present in mitotic spindles. (1989) (3)
Transcription of the Rous sarcoma virus genome in vitro and in vivo. (1975) (3)
ERYTHROPOIESIS DURING AMPHIBIAN METAMORPHOSIS (1971) (3)
Progress toward Public Access to Science (2008) (3)
Transgenic mice and host cell mutants resistant to transformation as model systems for identifying multiple components in oncogenesis. (1989) (3)
Genetic control of foetal and adult human haemoglobin. (1961) (3)
Impaired hematopoiesis and leukemia development in mice with a conditional “knock-in” allele of a mutant splicing factor gene U2af1 (2018) (3)
The stepwise reductive cleavage of DNP-peptides. (1956) (3)
Cell-Specific Transduction of Prdm1-Expressing Lineages Mediated by a Receptor for Avian Leukosis Virus Subgroup B (2009) (3)
Mutations of Cellular Oncogenes as a Basis for Neoplastic Change (1984) (3)
Ushering in a new age of scientific publishing (2000) (2)
Taxonomy and Sequence Relatedness of Retroviruses (1997) (2)
Binding in vitro of phosphotyrosine-containing proteins to pp60c-src SH2 domain does not correlate with CEF transformation. (1995) (2)
Synthesis of Gag and Gag-Pro-Pol Proteins (1997) (2)
NIH cancer chief wants more with less: by Meredith Wadman. (2011) (2)
The mutational landscape of EGFR-, MYC-, and Kras- driven genetically-engineered mouse models of lung adenocarcinoma (2016) (2)
Testimony Before the Special Committee on Aging United States Senate Statement of (2014) (2)
Sachi Prasad Ray-Chaudhuri (1987) (2)
Tadpole antibodies against frog hemoglobin and their effect on development. (1968) (2)
The weaknesses of science for profit. (2002) (2)
[Varmus's testimony before the Subcommittee on Health and Environment, Committee on Commerce, U.S. House of Representatives] (1998) (2)
Abstracts of papers presented at the 1985 Meeting on Molecular Biology of Hepatitis B Viruses, May 2-May 5, 1985 (1985) (2)
Recommendations for the nomenclature of hemoglobins. (1961) (2)
Harold Varmus. Interview by Errol C. Friedberg. (2008) (2)
Synthesis ofPlusStrands ofRetroviral DNA inCells Infected withAvianSarcoma Virus andMouseMammaryTumor Virust (1981) (2)
Retroviral “Lifestyles”: Simple versus Complex (1997) (2)
Experimental approaches to embryonic erythropoiesis. (1977) (2)
Gene evolution in the chicken beta-globin cluster. (1982) (2)
A mover in the biomedical community (2001) (2)
The Provirus of Rous Sarcoma Virus: Synthesis, Integration and Transcription (1975) (2)
The molecular origins of the disease are coming to light, suggesting several novel therapies (2003) (2)
Regulation of gene expression in Escherichia coli by cyclic AMP. (1971) (2)
Comparison of normal adult human haemoglobin with haemoglobin I by 'fingerprinting'. (1959) (2)
Sequence variation at the 5-terminal region in yeast s-RNA. (1965) (2)
National Institutes of Health in the tropics. (1998) (2)
Embryos, Cloning, Stem Cells, and the Promise of Reprogramming (2009) (2)
The challenge of making laws on the shifting terrain of science. (2000) (2)
Tadpoles, chicks, and red cells: a study of development. (1968) (1)
No money, no research (2014) (1)
Structural Classes of Retroelements and Replication Strategies (1997) (1)
Selective distribution of a novel tubulin in the developing and mature rat brain. (1990) (1)
Basic science and the NIH. (1994) (1)
cDNA sequence of a new chicken embryonic p-globin ( recombinant DNA / pBR 322 plasmid vector / DNA sequence determination / mRNA structure / hemoglobin switching ) (1)
No one is really immune (1993) (1)
Synthesis and Integration of Rous Sarcoma Virus Proviral DNA in Duck Embryo Fibroblast Cells (1975) (1)
Immune Responses to HIV and SIV (1997) (1)
Overview of Retroviral Assembly (1997) (1)
The Genetical Control of Protein Structure: The Abnormal Human Haemoglobins (2008) (1)
Control of hemoglobin expression in chick embryonic development. (1982) (1)
Viral Replication and Genetics (1973) (1)
Reverse Transcription of the Viral Genome in vivo (1997) (1)
Testimony of Harold Varmus, MD. . . . House Committee on Energy and Commerce and Senate Committee on Health, Education, Labor, and Pensions: "Managing Biomedical Research to Prevent and Cure Disease in the 21st Century: Matching NIH Policy with Science" (2003) (1)
Membrane Fusion and Viral Entry (1997) (1)
Public-access group supports PubMed Central (2002) (1)
THE WILLIAM ALLAN MEMORIAL AWARD LECTURE Human and Medical Genetics: A Scientific Discipline and an Expanding Horizon (2006) (1)
How Cancer Genomics Drives Cancer Biology: Does Synthetic Lethality Explain Mutually Exclusive Oncogenic Mutations? (2016) (1)
Erythropoiesis: Cellular and Molecular Mechanisms (1985) (1)
The crucial link between laboratory animal research and human health. (1991) (1)
Growth and Assay of Pathogenic Retroviruses (1997) (1)
Science Publishing and Science Libraries in the Internet Age (2009) (1)
Principles of Particle Assembly (1997) (1)
Transcription of chromatin in isolated nuclei by exogenous RNA polymerases (1978) (1)
Abnormal human haemoglobins. I. The comparison of normal human and sickle-cell haemoglobins by "fingerprinting". 1958. (1989) (1)
Public Library of Science Initiative - Open Letter (2000) (1)
Cellular Targets of Infection (1997) (1)
Outline of the Integration Process (1997) (1)
Abstract B35: Activation of Putative Compensatory Pathways upon Deletion of Erbb3 in Mutant EGFR-driven Lung Cancer (2012) (1)
Globin expression in Rous sarcoma virus-transformed quail myoblasts. (1983) (1)
YES1 amplification: a mechanism of acquired resistance to EGFR inhibitors identified by transposon mutagenesis and clinical genomics (2018) (1)
Alzheimer tangles and abnormal phosphorylation. (1995) (1)
Special Biological Features of Reverse Transcription (1997) (1)
Varmus Returns to His Roots in Cancer Genetics. (2015) (1)
Immunological and Pharmacological Approaches to the Control of Retroviral Infections -- Retroviruses (1997) (1)
Globin synthesis in fibroblasts fused with erythroblasts. II. Human fibroblasts (1975) (1)
US support for malaria research (1997) (1)
Small DNA Viruses (1993) (1)
Erratum: Uncensored exchange of scientific results (Proceedings of the National Academy of Sciences (2003) 100, 4, (1464) DOI: 10.1073/pnas.0630491100) (2012) (1)
Author response: Hyperactivation of ERK by multiple mechanisms is toxic to RTK-RAS mutation-driven lung adenocarcinoma cells (2018) (1)
Evolution of Retroelements and their Hosts (1997) (1)
An In Vivo Model To Investigate the Identity of the Cell-of-Origin of Multiple Myeloma. (2005) (1)
Retroviral Env Gene Products: Receptor Binding and Host-Range Determinants (1997) (1)
Of oncogenes and open science: an interview with Harold Varmus (2019) (1)
The DNA-methylating system of murine erythroleukemia cells. (1985) (1)
Dangers in EST Patent Law (2004) (1)
Homage to Howard Temin (1997) (1)
How Proto-oncogenes Participate in Cancer (2009) (1)
A Conversation with Michael Bishop & Harold Varmus (1992) (1)
Integration and expression of several molecular forms of Rous sarcoma virus DNA used for transfection of mouse cells (1984) (1)
Normal and Neoplastic Hematopoiesis. Proceedings of the UCLA Symposium Held at Steamboat Springs, Colorado, March 27-April 1, 1983.David W. Golde , Paul A. Marks (1984) (1)
Progress on All Fronts in Race to Map Genes (1998) (1)
A novel small molecule that induces cytotoxicity in lung cancer cells inhibits disulfide reductases GSR and TXNRD1 (2021) (1)
Embryonic determination and differentiation. (1980) (1)
Retroviruses and their Interactions with the Host Cell (1997) (0)
Letter from Harold Varmus to Edward Fritsch, McArdle Laboratory for Cancer Research (1976) (0)
Letter from Harold Varmus to Barbara H. Sanford, The Jackson Laboratory (1982) (0)
Retraction. Moloney murine leukemia virus integration protein produced in yeast binds specifically to viral att sites (1991) (0)
Letter from Harold Varmus to Robin Weiss, National Cancer Institute (1974) (0)
Planning of US AIDS research (1996) (0)
Letter: Evidence for non-repetitive subunits in the genome of Rous sarcoma virus. (1974) (0)
Letter from Harold Varmus to Kumao Toyoshima, Institute of Medical Science (Japan) (1982) (0)
Letter from Harold Varmus to J. Michael Bishop (1985) (0)
Session 6: Stem Cells (2004) (0)
THE ETHICSOFHIVRESEARCH IN DEVELOPINGNATIONS (1998) (0)
Create a COVID-19 commission. (2021) (0)
Letter from Harold Varmus to T. Ando, Institute of Physical and Chemical Research (Japan) (1971) (0)
A Mutation inv-srcThatRemovesa Single Conserved Residue in theSH-2Domainofpp6Ov-src Restricts Transformation ina Host-Dependent Manner (1989) (0)
Letter from Harold Varmus to Efraim Racker, Cornell University (1989) (0)
Letter from Harold Varmus to Dani P. Bolognesi, Duke University Medical Center (1985) (0)
Letter from Harold Varmus to Robert C. Gallo, National Institutes of Health (1982) (0)
Maturation of Viral Particles (1997) (0)
Biochemistry of Reverse Transcription (1997) (0)
Mutational analysis of EGFR signaling pathway genes in lung adenocarcinomas (2007) (0)
Structures of unintegrated and integrated forms of the deoxyribonucleic acid of ribonucleic acid tumour viruses. (1979) (0)
Letter from Harold Varmus to Girish N. Vyas (1977) (0)
DNA Methylation and Epigenetic Inheritance in Plants and Filamentous Fungi (2001) (0)
Abstract C113: ERBB3 independent activation of the PI3K pathway in EGFR mutant lung adenocarcinomas. (2013) (0)
Nucleic Acids Research Is There Specific Transcription from Isolated Chromatin? Nucleic Acids Research (0)
TO ADDRESS THE 37 th ANNUAL MACUB CONFERENCE AT LONG ISLAND UNIVERSITY (2004) (0)
Letter from Harold Varmus to Peter Bentvelzen, Radiobiological Institute of the Organization for Health Research (The Netherlands) (1975) (0)
[The structure of abnormal hemoglobins]. (1958) (0)
Functional Characterization of Mammary Stem Cells (2004) (0)
Letter from Harold Varmus to James D. Watson, Cold Spring Harbor Laboratory (1983) (0)
Active Immunization of Tadpoles against Frog Hemoglobin and Developmental Consequences (1971) (0)
Arlen Specter: A retrospective (2012) (0)
Letter from Harold Varmus to Bill McGuire, United States Information Agency (1989) (0)
475. The stereochemistry of 10-benzylideneanthrone and 9-benzylidenefluorene (1950) (0)
Analogues de daph et inhibition d'agregation de proteines (2005) (0)
Letter from Harold Varmus to Howard Young, National Cancer Institute (1979) (0)
Letter from Harold Varmus to Paul Hough, Cold Spring Harbor Laboratory (1973) (0)
P1-191 Blocking the initial molecular mechanism of Alzheimer's disease (2004) (0)
Mutational Consequences of Retroelements in the Germ Line (1997) (0)
Synthesis and Integration of Virus-specific DNA in Cells Infected by RNA Tumor Viruses (1978) (0)
Memorandum from Harold Varmus to the Grand Challenges in Global Health Scientific Advisory Board (2007) (0)
ERYTHROPOIESIS DURING AMPHIBIAN METAMORPHOSIS (1971) (0)
Winning the arguments on Capitol Hill (2009) (0)
Bad Times and Good Times as NIH Director (2009) (0)
Reversing the Formation of Alzheimer Amyloid Fibrils and Blocking Toxic Ca2+ Influx (2004) (0)
Abstract 2328: Polyethnic-1000: Advancing cancer genomics by studying ethnically diverse, underserved patient populations in New York (2020) (0)
THE GENESIS OF AVIAN RETROVIRUS ONCOGENES (1980) (0)
Gene Regulation and Oncogenesis by Retroviruses (1981) (0)
Letter from Harold Varmus to Paul Neiman, Providence Hospital (1975) (0)
On the biosynthesis of hemoglobin. (1967) (0)
Epilogue: A Life in Science (2009) (0)
Utilizations neurofilament protein kinase / tau PK40. (1992) (0)
Embryonic Erythropoiesis: Some Experimental Systems (2008) (0)
Accessory Proteins and Assembly (1997) (0)
RECOMMENDATIONS FOR THE NOMENCLATURE OF HÆMOGLOBINS (1961) (0)
Plenary Address: Molecular Disease (1981) (0)
An overview of the FY‐1996 budget for the National Institutes of Health (1995) (0)
Report of the 3rd International Congress of Virology (1975) (0)
Immunopathogenic Mechanisms of HIV Infection (1997) (0)
Recommendations for nomenclature of hemoglobins. (1979) (0)
Memorandum from Harold Varmus to members of the human retrovirus subcommittee of the Retrovirus Study Group [on the results of the initial straw poll on the nomenclature of the AIDS virus] (1985) (0)
Letter from Harold Varmus to Edward Fritsch and Howard M. Temin, McArdle Laboratory for Cancer Research (1976) (0)
SH 2 mutants of csrc that are host dependent for transformation are trans-dominant inhibitors of mouse cell transformation by activated csrc (2007) (0)
Letter from Harold Varmus to George F. Vande Woude, National Institutes of Health (1980) (0)
Memorandum from Harold Varmus to the Secretary of Health and Human Services (1997) (0)
Interaction of Wnt-1 proteins with the binding protein BiP (1992) (0)
The Hemoglobins of the Fetus (1971) (0)
9.110J / 7.92J Neurology, Neuropsychology, and Neurobiology of Aging, Spring 2003 (2003) (0)
457. A molecular compound of anthraquinone and dianthron-9-yl (1950) (0)
(retrovirus DNA/circular DNA/terminal repeat/control regions/prim (2016) (0)
Definition ofRegions inHumanc-mycThatAreInvolved in Transformation andNuclear Localization (1987) (0)
For the ICRF Annual Report, 1979: I. The Rare Revertants of an ASV-Transformed Rat Cell Have Lost Proviral DNA or Bear Mutations in SRC (1979) (0)
A conversation with Harold Varmus. Interview by Ushma S. Neill. (2012) (0)
Applications of TAU / neurofilamentproteinkinasen PK40 (1992) (0)
Memorandum from Harold Varmus to members of the human retrovirus subcommittee of the Retrovirus Study Group [with the initial set of proposals on the nomenclature of the AIDS virus] (1985) (0)
An overview of the FY-1996 budget for the National Institutes of Health. (1995) (0)
Letter from Harold Varmus to John Garamendi, California State Senate (1987) (0)
Hyperactivation of extracellular signal-regulated kinase (ERK) by RAS-mediated signaling or inhibition of dual specificity phosphatase 6 (DUSP6) is associated with toxicity in lung adenocarcinoma cells with mutations in KRAS or EGFR (2017) (0)
Letter from Harold Varmus to U.S. Senator Dick Durbin (2006) (0)
Letter from Vernon M. Ingram to Francis Crick (1965) (0)
Basic Science andTheNIH (1994) (0)
Letter from Harold Varmus to Hsing-Jien Kung, Michigan State University (1982) (0)
Viruses as Vehicles of Genetic Change (1976) (0)
The Integration Reaction (1997) (0)
Recommendations for the nomenclature of hemoglobins (2005) (0)
Letter from Harold Varmus to the Passano Foundation (1983) (0)
CONTROL MECHANISMS IN HEMOGLOBIN SYNTHESIS. (1964) (0)
Letter from Harold Varmus to Yoji Ikawa, Japanese Foundation for Cancer Research (1981) (0)
Transgenes expressing the Wnt-1 and int-2 proto-oncogenes cooperate during mammary carcinogenesis in doubly transgenic mice (1992) (0)
NIH Plan for Research in Spinal Cord Injury and Regeneration (1996) (0)
Abstract A18: Reduced NF1 expression in resistance to EGF receptor inhibitory drugs in lung adenocarcinoma (2012) (0)
Forum for Agricultural Biotechnology Debates (2001) (0)
Recommendations for the nomenclature of haemoglobins. (1961) (0)
Features of the chicken c-myc gene that influence the structure of c-myc RNA in normal cells and bursal lymphomas (1986) (0)
Testimony by Harold Varmus, MD, to the Senate Judiciary Committee Hearing on Human Cloning (2003) (0)
For the ICRF Annual Report, 1979: III. Co-Transfection with Papovavirus and Retrovirus DNA Using Recombinant DNA Prepared In vitro (1979) (0)
Letter from Harold Varmus to Julius R. Krevans (1980) (0)
Letter from Harold Varmus to Jean Marx, Science Magazine (1984) (0)
SH groups in haemoglobins. (1954) (0)
Letter from Harold Varmus to Donald S. Fredrickson, National Institutes of Health (1979) (0)
Figure 16, [Retroviral 3′-end processing and polyadenylation...]. (1997) (0)
Retroviruses as Agents of Genetic Change (1997) (0)
Hyperactivation of ERK by multiple mechanisms is toxic to RTK-RAS mutation-driven lung 1 adenocarcinoma cells 2 3 4 (0)
Runx1 Deficiency and MDS-Associated U2af1 Mutation Cooperate for Leukemia Development in a New Mouse Model (2016) (0)
Letter from Harold Varmus to U.S. Senator Arlen Specter (1996) (0)
Partnerships in Science (2009) (0)
Biochemical Activities and Assays (1997) (0)
Role of Lymphoid Organs in Immunopathogenesis (1997) (0)
Public health. Proliferation of National Institutes of Health. (2001) (0)
For the ICRF Annual Report, 1979: II. Retroviruses as Mutagens: Isolation of Revertants with Deletions and/or Insertions in the ASV Provirus in B31 Cells after Superinfection with MuLV (1979) (0)
Abstract LB-398: Identification of novel mechanisms of resistance to EGFR tyrosine kinase inhibitors in non-small cell lung cancer (2011) (0)
DNA methylation of remote sequences in chicken alpha-globin gene expression. (1983) (0)
Letter from Harold Varmus to D. P. Georgiev, Academy of Sciences (U.S.S.R.) (1982) (0)
Immunological Approaches to Controlling Retroviral Infection (1997) (0)
Figure 3, [Three distinct pathways for retroviral...]. (1997) (0)
Table 3, Other HIV-1 Vaccine Approaches (1997) (0)
Abstract 4163: Molecular and physiological effects of splicing factor mutant U2AF1 in human lung cell lines and in mice (2016) (0)
Letter from Harold Varmus to Salvador E. Luria (1975) (0)
A Prize for Cancer Prevention (2017) (0)
The First Taste of Scientific Success (2009) (0)
A Prize for Cancer Prevention (2017) (0)
Letter from Harold Varmus to Luis M. de la Maza, University of Minnesota (1974) (0)
Targeted Therapies for Human Cancers (2009) (0)
Being NIH Director (2009) (0)
Correct Integration of Rettwiral DNA In Vitro - (2003) (0)
The biosynthesis of macromolecules / by Vernon M. Ingran (1966) (0)
NIH funds support more than a researcher's own lab (2008) (0)
Abstract A39: Initial characterization of genetically engineered mice carrying a conditional allele of a splicing factor gene (U2AF1) commonly mutated in myeloid disorders. (2015) (0)
Letter from J. Michael Bishop, Marc Kirschner, Elizabeth Marincola, and Harold Varmus to Paul Berg, Donald D. Brown, and Maxine Singer (1992) (0)
Letter from Harold Varmus to Dominique Stehelin (1976) (0)
Letter from Harold Varmus to Tim Gorski (1975) (0)
Letter from Harold Varmus to fellow clinicians who work with AIDS patients on their suggestions for naming the AIDS virus (1985) (0)
[Career summary and research proposal sent to the Josiah Macy, Jr. Foundation] (1977) (0)
EMail from Harold Varmus to Richard Klausner et al (2003) (0)
Viral RNA Packaging (1997) (0)
Receptor-Mediated Barriers to Retroviral Infection (1997) (0)
Letter from Harold Varmus to Joyce Wallace (1985) (0)
Electron Solvation in Finite Systems : Femtosecond Dynamics of Iodide z ( Water ) n Anion Clusters (1999) (0)
The United States needs a department of technology and science policy. (2021) (0)
Site-directed mutagenesis of the SH2- and SH3-coding domains of c-src produces varied phenotypes, including oncogenic activation of p60c-src (1990) (0)
Isolation of duplicated human c-src genes located on chromosomes 1 and 20 (1985) (0)
Discussion Points for NIH Technology Transfer Advisory Committee (1994) (0)
The Use of cDNA Microarray to Study Gene Expression in Wnt-1 Induced Mammary Tumors (2002) (0)
Harold Varmus, director, National Institutes of Health. Interview by Richard Horton. (1994) (0)
Letter from Harold Varmus to Mike Scott, Imperial College of Science and Technology (1982) (0)
Wild-type Splicing Factor U2AF1 inhibits splicing associated with a recurrent U2AF1 mutant in human lung cancers and is required for cell survival (2016) (0)
Borne on the Winds of War (2002) (0)
envGeneofChicken RNATumorViruses: Extent of Conservation inCellular andViral Genomes (1978) (0)
Letter from Harold Varmus to Natalie Teich, Imperial Cancer Research Fund Laboratories (1982) (0)
Letter from Harold Varmus to Kalman Perk, School of Veterinary Medicine, Hebrew University of Jerusalem (1984) (0)
Stanford Medical School Graduation Speech (1997) (0)
Immune Response to Retroviral Infection (1997) (0)
The Enlightenment Returns (2009) (0)
Letter from Paul Berg, Lawrence S. B. Goldstein, H. Robert Horvitz, Thomas D. Pollard, and Harold Varmus to U.S. President Bill Clinton (2000) (0)
Abstract 3166: Lung cancer bio-signatures in plasma based on the analysis of mouse models (2011) (0)
Letter from Harold Varmus to Alan C. Davis, American Cancer Society (1982) (0)
Letter from Harold Varmus to Senator Tom Harkin (1997) (0)
Effects of Proviral Integration on Host Gene Expression (1997) (0)
Letter from Harold Varmus to John Z. Bowers, Josiah Macy, Jr. Foundation (1977) (0)
Letter from Harold Varmus to Benjamin Lewin, Massachusetts Institute of Technology Press (1976) (0)
Letter from Harold Varmus to Lawrence A. Donehower, National Institutes of Health (1981) (0)
AIDS: The Process of Discovery (1997) (0)
The RSV Oncogene and Its Progenitor (2009) (0)
Augmented expression of normal c-myc is sufficient for cotransformation of rat embryo cells with a mutant ras gene (1985) (0)
Letter from Harold Varmus to Anthony L. Schincariol, Duke University Medical Center (1974) (0)
Letter from Harold Varmus to Maxine Singer (1990) (0)
Science Policy in the Next Forty Years (1999) (0)
Isolation ofDuplicated Humanc-src GenesLocated on Chromosomes 1and20 (1985) (0)
Abstract A072: Polyethnic-1000: Advancing cancer genomics by studying ethnically diverse, underserved patient populations in New York (2020) (0)
Letter from J. Michael Bishop and Harold Varmus to Harry D. Williams II, American Business Cancer Research Foundation (1983) (0)
Nucleotide sequence and expression in vitro of cDNA derived from mRNA of int-1, a provirally activated mouse mammary oncogene (1985) (0)
EMail from Patrick O. Brown, Michael Eisen and Harold Varmus to Edward S. Yoon (2002) (0)
Washington University Record, February 16, 1995 (2014) (0)
Abstract B063: Polyethnic-1000: Advancing cancer genomics by studying ethnically diverse, underserved patient populations in New York (2020) (0)
Should the Endless Frontier of Federal Science be Expanded? (2021) (0)
Comparison to Other Gene Transfer Systems (1997) (0)
Global Science and Global Health (2009) (0)
Memorandum from Harold Varmus to members of the human retrovirus subcommittee of the Retrovirus Study Group [on a response to a letter from Robert Gallo] (1986) (0)
Foreword to National Sleep Disorders Research Plan, National Institutes of Health, March 1996 (1997) (0)
Memorandum from Harold Varmus to members of the human retrovirus subcommittee of the Retrovirus Study Group [on the final proposal to the medical journals on the nomenclature of the AIDS virus] (1986) (0)
Site of integration of oncogenic viruses in mammalian chromatin. Abstr. (1974) (0)
Letter from Harold Varmus to Max Essex, Harvard School of Public Health (1985) (0)
P1.02-073 Characterizing the Genomes of Lung Adenocarcinomas from Never Smokers Reveals SHPRH as a Novel Candidate Tumor Suppressor Gene: Topic: Other Mutations in Thoracic Malignancies (2017) (0)
The int-1 proto-oncogene products are glycoproteins that appear to enter the secretory pathway (1987) (0)
Rearrangement atthe5'EndofAmplified c-mycinHumanCOLO 320Cells IsAssociated withAbnormal Transcription (1986) (0)
Retrovirus-Induced Immunodeficiencies (1997) (0)
[Transcript of Varmus's testimony at Congressional Hearing "Biotechnology and the Ethics of Cloning: How Far Should We Go?"] (1997) (0)
Is Science Under Siege (2005) (0)
Letter from Harold Varmus and J. Michael Bishop to Robert J. Huebner, National Cancer Institute (1972) (0)
Letter from Herbert W. Boyer, Philip Coffino, and Harold Varmus to Daphne Kamely, National Institute of General Medical Sciences (1977) (0)
From Literature to Medicine to Science (2009) (0)
NIH R&D priorities. (1994) (0)
Letter from Harold Varmus to E. C. C. Lin, Harvard Medical School (1973) (0)
Characterization of a small molecule inhibitor of disulfide reductases that induces oxidative stress and lethality in lung cancer cells. (2022) (0)
The Road to Building One (2009) (0)
Memorandum from Harold Varmus to members of the human retrovirus subcommittee of the Retrovirus Study Group [on the latest status on the efforts to name the AIDS virus] (1985) (0)
Mutational profiling of the oncogenome in non-small cell lung cancer (NSCLC) (2005) (0)
Memorandum from Harold Varmus to Keith Hadley, Campus Biosafety Committee, University of California, San Francisco (1979) (0)
Memorandum from Harold Varmus to Gladys Kist and Susan Shultz [on grant application for 1985 Hepatitis B Virus Meeting] (1984) (0)
[Excerpt from Varmus' notebook from the Gordon Conference on Animal Cells and Viruses] (1975) (0)
Update from the Hill: budget battle. (2011) (0)
Under the Influence: from the Provirus Hypothesis to Multistep Carcinogenesis (1995) (0)
Political Scientist (2009) (0)
Retroviruses and their Interactions with Multicellular Hosts (1997) (0)
Letter from Harold Varmus to prospective Scientific Advisory Board members (2003) (0)
Letter from Harold Varmus to Hisayuki Yamamura, Japan Medical Research Foundation (1981) (0)
Letter from Harold Varmus to Michael I. Goldberg (1999) (0)
Figure 11, [Linear representation of the ASLV...]. (1997) (0)
P1.02-055 Synthetic Lethality Dictates the Mutual Exclusivity of Oncogenic Mutations in Lung Adenocarcinoma: Topic: Driver Genes in NSCLC, Resistance, and Other (2017) (0)
Letter from Harold Varmus and Stephen Hughes to Ed Southern, Medical Research Council of Great Britain (1978) (0)
Replication, Differentiation, and the Cell Cycle (1997) (0)
Letter from Harold Varmus to David W. Kingsbury, Sir William Dunn School of Pathology, University of Oxford (1984) (0)
Incorporation of Env into the Viral Particle (1997) (0)
The Retroviral Protease (1997) (0)
Letter from Harold Varmus to Jon Beckwith, Department of Microbiology and Molecular Genetics, Harvard Medical School (1986) (0)
Letter from Harold Varmus to Philip Leder, Harvard Medical School (1983) (0)
Models for Virion Structure (1997) (0)
Letter from Harold Varmus to David W. Kingsbury, St. Jude Children's Research Hospital (1984) (0)
Using Recombinant DNA Technology to Study the Behavior of Retroviruses (1983) (0)
Oncogenesis without Viral Oncogenes by Avian Leukosis and Mouse Mammary Tumor Viruses (1983) (0)
Retraction (2021) (0)
The Development of Retrovirology as Intellectual History (1997) (0)
Analysis of DNA sequence copy number variations by comparative genomic hybridization (CGH) (1995) (0)
Letter from Harold Varmus to John S. Cole III, National Institutes of Health (1982) (0)
How the US can best support the careers of promising young biomedical scientists (2018) (0)
Rearrangement at the 5' end of amplified c-myc in human COLO 320 cells is associated with abnormal transcription (1986) (0)
Letter from Harold Varmus to Mike Fried, Art, Herman and Nancy Quintrell (1978) (0)
Gordon Tomkins (1975) (0)
Letter from Harold Varmus to Robert A. Weinberg, Massachusetts Institute of Technology (1983) (0)
Letter from Harold Varmus to Mike Fried, Imperial Cancer Research Fund Laboratories (1977) (0)
Generation of pulmonary neuro-endocrine cells and tumors resembling small cell lung cancers from human embryonic stem cells (2018) (0)
Memorandum from Harold Varmus to members of the human retrovirus subcommittee of the Retrovirus Study Group [on their final response on the nomenclature of the AIDS virus] (1986) (0)
Host Genes that Influence Pathogenesis (1997) (0)
Letter from Harold Varmus, Warren Levinson, and J. Michael Bishop to Peter K. Vogt, University of Washington School of Medicine (1971) (0)
B13 Selectively Targeting Lung Cancer with a Novel Small Molecule that Induces Lethality Through Dual Inhibition of Disulfide Reductases (2020) (0)
Harold Varmus. Interview by Errol C. Friedberg. (2008) (0)
Letter from Harold Varmus to David Baltimore, Institute of Cancer Research (1980) (0)
Effect of Infection on Cell Division and Differentiation (1997) (0)
New York’s Polyethnic-1000: a regional initiative to understand how diverse ancestries influence the risk, progression, and treatment of cancers (2021) (0)
Tissue-Specific Disease and Organ System Failure (1997) (0)
Letter from Harold Varmus to Howard M. Temin, McArdle Laboratory for Cancer Research (1985) (0)
The src protein contains multiple domains for specific attachment to membranes (1990) (0)
Embryo research guidelines. (1994) (0)
[Excerpt from UCSF School of Medicine's Department of Biochemistry and Biophysics' 1982-1983 Annual Report] (1983) (0)
Retroviruses and Their Replication Cycle (2009) (0)
Organization of Genes in Prototypic Retroviruses (1997) (0)
Letter from Harold Varmus to Richard Lerner, Scripps Clinic and Research Foundation (1983) (0)
Letter from Harold Varmus to Peter K. Vogt, University of Southern California School of Medicine (1975) (0)
The challenges of an HIV vaccine enterprise - Response (2004) (0)
The first seven amino acids encoded by the v-src oncogene act as a myristylation signal: lysine 7 is a critical determinant (1988) (0)
View from the top of a biomedical empire. Interview by Eliot Marshall. (1999) (0)
Letter from Harold Varmus to Michael G. P. Stoker, Imperial Cancer Research Fund Laboratories (1977) (0)
Letter from Harold Varmus to Lennert Phillipson, Waltenberg Labs (1971) (0)
Abstract LB-151: Targeted gene resequencing in a K-ras-dependent mouse model of metastatic lung adenocarcinoma (2010) (0)
Basic fibroblast growth factor ii proliferation after glia-specific { (2016) (0)
Letter from Harold Varmus to Lloyd J. Old, Sloan-Kettering Institute for Cancer Research (1972) (0)
Letter from Harold Varmus to Marilyn Kozak, University of Pittsburgh (1983) (0)
Binding of the Src SH2 domain to phosphopeptides is determined by residues in both the SH2 domain and the phosphopeptides (1993) (0)
Non-conserved metabolic regulation by LKB1 distinguishes human and mouse lung adenocarcinoma (2021) (0)
Transmission and Epidemiology (1997) (0)
The Best of Retrotrivia (1997) (0)
Letter from Harold Varmus to Don Robertson, Washington University (1976) (0)
Figure 13, [Ribbon diagram of the dimeric...]. (1997) (0)
Summary and Perspectives (1997) (0)
Harold E. Varmus, MD. (1995) (0)
BECOMING A SCIENTIST (2009) (0)
Letter from Harold Varmus to David Boettiger, Imperial Cancer Research Fund Laboratories (1974) (0)
MOLECULAR AND GENETIC APPROACHES TO RETROVIRUSES AND ONCOGENES (0)
Letter from John M. Coffin and Harold Varmus to their colleagues (1981) (0)
Letter from Harold Varmus to Paul Neiman, University of Washington Department of Medicine (1972) (0)
Pathogenesis of Kaposi's Sarcoma and Other Opportunistic Neoplasms (1997) (0)
EMail from Harold Varmus to Christopher Reeve (1996) (0)
Profiling Oncology Drug Candidates Through Complementary in vitro Assays and in vivo Models to Better Understand Their Potential Clinical Applications (2019) (0)
Letter from Harold Varmus to F. Kisseljou, D. I. Ivanovsky Virology Institute (1972) (0)
How popular TV shows shape public perceptions of medical scientists. (2001) (0)
Other Retrovirus-Induced Diseases (1997) (0)
Memorandum from Harold Varmus to members of the human retrovirus subcommittee of the Retrovirus Study Group [on the latest poll regarding the nomenclature of the AIDS virus] (1985) (0)
Abstract 5128: Polyethnic-1000: Advancing cancer genomics by studying ethnically diverse, underserved patient populations in New York (2019) (0)
[Varmus' remarks at the unveiling of his portrait at NIH] (2003) (0)
[Progress report from "Molecular Analysis of Retroviruses and Oncogenes" grant project] (1985) (0)
Impaired hematopoiesis and leukemia development in mice with a "knock-in" allele of U2af1(S34F) (2018) (0)
Letter from Harold Varmus to Erling Norrby, Department of Virology, Karolinska Institute (1987) (0)
Figure 5, [Strategies for packaging cell line...]. (1997) (0)
Letter from Harold Varmus to Ed Southern, Medical Research Council of Great Britain (1977) (0)
Mammary-Specific Gene Transfer for Modeling Breast Cancer (2000) (0)
From Problems and Politics to the Communal Experience in Science : An Interview with (2016) (0)
The mouse Wnt-1 gene can act via a paracrine mechanism in transformation of mammary epithelial cells (1992) (0)
Letter from Harold Varmus to Howard B. Hamilton, Radation Effects Research Foundation (1982) (0)
Letter from Harold Varmus to Ian Macpherson, Imperial Cancer Research Fund Laboratories (1972) (0)
Letter from Harold Varmus to Charles A. Thomas, Jr., Harvard Medical School (1971) (0)

This paper list is powered by the following services:

Other Resources About Harold E. Varmus

What Schools Are Affiliated With Harold E. Varmus?

Harold E. Varmus is affiliated with the following schools:

Harold E. Varmus's AcademicInfluence.com Rankings

Image Attributions

Image Source for Harold E. Varmus